
Evaxion Biotech A/S
NASDAQ:EVAX

Intrinsic Value
The intrinsic value of one
EVAX
stock under the Base Case scenario is
77.36
USD.
Compared to the current market price of 3.04 USD,
Evaxion Biotech A/S
is
Undervalued by 96%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Fundamental Analysis


Revenue & Expenses Breakdown
Evaxion Biotech A/S
Balance Sheet Decomposition
Evaxion Biotech A/S
Current Assets | 8.8m |
Cash & Short-Term Investments | 6m |
Receivables | 1.5m |
Other Current Assets | 1.3m |
Non-Current Assets | 3.7m |
PP&E | 3.5m |
Other Non-Current Assets | 206k |
Free Cash Flow Analysis
Evaxion Biotech A/S
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Evaxion Biotech A/S
Revenue
|
3.3m
USD
|
Operating Expenses
|
-17.5m
USD
|
Operating Income
|
-14.2m
USD
|
Other Expenses
|
862k
USD
|
Net Income
|
-13.3m
USD
|
EVAX Profitability Score
Profitability Due Diligence
Evaxion Biotech A/S's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Score
Evaxion Biotech A/S's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
EVAX Solvency Score
Solvency Due Diligence
Evaxion Biotech A/S's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Score
Evaxion Biotech A/S's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EVAX Price Targets Summary
Evaxion Biotech A/S
Dividends
Current shareholder yield for EVAX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?